Glial growth is regulated by agonists selective for multiple opioid receptor types in vitro
about
Mitogenic signaling via endogenous kappa-opioid receptors in C6 glioma cells: evidence for the involvement of protein kinase C and the mitogen-activated protein kinase signaling cascadeSciatic nerve ligation-induced proliferation of spinal cord astrocytes is mediated by kappa opioid activation of p38 mitogen-activated protein kinaseOpioid system diversity in developing neurons, astroglia, and oligodendroglia in the subventricular zone and striatum: impact on gliogenesis in vivoInteractions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.Glial-restricted precursors: patterns of expression of opioid receptors and relationship to human immunodeficiency virus-1 Tat and morphine susceptibility in vitro.Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.Morphine and gp120 toxic interactions in striatal neurons are dependent on HIV-1 strain.Opiate drug use and the pathophysiology of neuroAIDS.Molecular targets of opiate drug abuse in neuroAIDS.Mu-opioid agonist inhibition of kappa-opioid receptor-stimulated extracellular signal-regulated kinase phosphorylation is dynamin-dependent in C6 glioma cellsBeta-endorphin is a potent inhibitor of thymidine incorporation into DNA via mu- and kappa-opioid receptors in fetal rat brain cell aggregates in culture.Dynorphins modulate DNA synthesis in fetal brain cell aggregates.kappa-Opioid agonist modulation of [3H]thymidine incorporation into DNA: evidence for the involvement of pertussis toxin-sensitive G protein-coupled phosphoinositide turnoverDifferential expression and HIV-1 regulation of μ-opioid receptor splice variants across human central nervous system cell types.Does the kappa opioid receptor system contribute to pain aversion?Evidence for kappa- and mu-opioid receptor expression in C6 glioma cellskappa-opioid receptor expression defines a phenotypically distinct subpopulation of astroglia: relationship to Ca2+ mobilization, development, and the antiproliferative effect of opioids.Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat.Regional, developmental, and cell cycle-dependent differences in mu, delta, and kappa-opioid receptor expression among cultured mouse astrocytes.CCL5/RANTES gene deletion attenuates opioid-induced increases in glial CCL2/MCP-1 immunoreactivity and activation in HIV-1 Tat-exposed mice.CCR2 mediates increases in glial activation caused by exposure to HIV-1 Tat and opiates.Endogenous opioid system in developing normal and jimpy oligodendrocytes: mu and kappa opioid receptors mediate differential mitogenic and growth responses.Receptor-activated Ca2+ increases in vibrodissociated cortical astrocytes: a nonenzymatic method for acute isolation of astrocytes.Opiate Drugs with Abuse Liability Hijack the Endogenous Opioid System to Disrupt Neuronal and Glial Maturation in the Central Nervous System.
P2860
Q24647045-1C123438-E56E-4130-9526-8E5D0B991367Q24683304-52AF385E-F6F2-4E0F-8C41-0C33F365A767Q28360384-86EB5202-D946-4072-8C16-34FC0B962FAEQ35007339-EF882D0F-CBD4-4EBC-A008-035C3C0F5556Q35019404-2DC1A245-0935-4260-A68C-838EC12BDA4EQ35122783-48AD4112-ECA8-4285-AA5E-5D575E3B36DEQ35857045-5F0397F9-D113-41BA-826F-7EF5B0B3FEBDQ36201412-DBDD6206-335B-4043-AAB2-3644A531FACBQ36302053-B078CD46-9DBD-4F00-909C-598E3D10AA90Q36946620-A9B59D05-CB3F-448B-B00F-39F839D28AA4Q36946625-28077091-8EE9-4397-9072-F78DBB731A5BQ36968263-56FEB790-4D81-40CC-BC63-9E17CB21AB25Q36982839-B96FC72C-9446-4260-BC44-9C682FDB6056Q37064333-212D823E-B4A2-4D39-BE6E-BA25B9055FCDQ38276410-0D75F6E4-2DDF-4C04-8D09-9D94429875D1Q41046298-BBF138B7-3365-433A-BA9A-81AF9EAFB04EQ41132298-0DEB2B12-DDB7-4C13-B0B4-2090119BB187Q41841039-E914D20A-D397-48CE-AD13-BF6323D12322Q41943142-D47EAAA8-829E-4B30-9A87-69C864E53767Q42135420-151E979F-0175-474D-A80E-FED2D27D846BQ43123425-CC2A4B5D-15D7-498D-AB00-8F096BDD5945Q44348322-CB2BF788-8B5F-4DBF-9E20-69EA0D867A67Q48348647-E28BC9DF-D0AC-4159-BCD3-7484C69D2F63Q49270407-E1F7B6D5-B317-462A-925A-48E500C7AC09
P2860
Glial growth is regulated by agonists selective for multiple opioid receptor types in vitro
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Glial growth is regulated by a ...... opioid receptor types in vitro
@ast
Glial growth is regulated by a ...... opioid receptor types in vitro
@en
type
label
Glial growth is regulated by a ...... opioid receptor types in vitro
@ast
Glial growth is regulated by a ...... opioid receptor types in vitro
@en
prefLabel
Glial growth is regulated by a ...... opioid receptor types in vitro
@ast
Glial growth is regulated by a ...... opioid receptor types in vitro
@en
P2860
P356
P1476
Glial growth is regulated by a ...... opioid receptor types in vitro
@en
P2093
A Stiene-Martin
K F Hauser
P2860
P304
P356
10.1002/JNR.490290415
P577
1991-08-01T00:00:00Z